株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

肝臓癌診断市場:スクリーニングタイプ、エンドユーザー、地域別の分析、シェア、動向、規模、予測(2020年~2026年)

Liver Cancer Diagnostic Market, By Screening Type, By End User, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

発行 AnalystView Market Insights 商品コード 941398
出版日 ページ情報 英文 183 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
肝臓癌診断市場:スクリーニングタイプ、エンドユーザー、地域別の分析、シェア、動向、規模、予測(2020年~2026年) Liver Cancer Diagnostic Market, By Screening Type, By End User, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
出版日: 2020年06月01日 ページ情報: 英文 183 Pages
概要

世界の肝臓癌診断市場は、2019年に93億5,000万米ドルとなりました。同市場は、2020年から2026年の予測期間中に8%のCAGRで成長する見通しです。

当レポートは世界の肝臓癌診断市場について調査しており、市場機会や動向、成長および抑制要因、スクリーニングタイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 市場概要

第2章 エグゼクティブサマリー

  • 市場セグメント
    • スクリーニングタイプ別
    • エンドユーザー別
    • 地域別
  • 競合考察

第3章 主要市場動向

  • 市場成長要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 業界調査

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制枠組み分析
  • COVID-19影響分析

第5章 市場情勢

  • 市場シェア分析
  • 主な革新者
  • 主要メーカー別の内訳データ
    • 既存企業分析
    • 新興企業分析

第6章 市場分析:スクリーニングタイプ別

  • 概観
    • セグメントシェア分析
  • 生検
  • 内視鏡検査
  • イメージング
  • 臨床検査
    • 血液検査
    • バイオマーカー

第7章 市場分析:最終用途別

  • 概観
    • セグメントシェア分析
  • 独立研究所
  • 病院関連研究所
  • 癌研究機関
  • その他

第8章 市場分析:地域別

  • イントロダクション
    • セグメントシェア分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 ベンダーの分析

  • Thermo Fisher Scientific.
    • 会社のスナップショット
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen
  • Danaher Corporation

第10章 アナリストの見解

第11章 付録

  • 調査手法
  • 参考文献
  • 略語
  • 免責事項
  • お問い合わせ
図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liver Cancer Diagnostic market: Screening Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Screening Type
  • TABLE Global Liver Cancer Diagnostic market, by Screening Type 2015-2026 (USD Million)
  • TABLE Liver Cancer Diagnostic market: End User Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Liver Cancer Diagnostic market, by End User 2015-2026 (USD Million)
  • TABLE Liver Cancer Diagnostic market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liver Cancer Diagnostic market, by Region 2015-2026 (USD Million)
  • TABLE North America Liver Cancer Diagnostic market, by Country, 2015-2026 (USD Million)
  • TABLE North America Liver Cancer Diagnostic market, by Screening Type, 2015-2026 (USD Million)
  • TABLE North America Liver Cancer Diagnostic market, by End User, 2015-2026 (USD Million)
  • TABLE Europe Liver Cancer Diagnostic market, by country, 2015-2026 (USD Million)
  • TABLE Europe Liver Cancer Diagnostic market, by Screening Type, 2015-2026 (USD Million)
  • TABLE Europe Liver Cancer Diagnostic market, by End User, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liver Cancer Diagnostic market, by country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liver Cancer Diagnostic market, by Screening Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liver Cancer Diagnostic market, by End User, 2015-2026 (USD Million)
  • TABLE Latin America Liver Cancer Diagnostic market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Liver Cancer Diagnostic market, by Screening Type, 2015-2026 (USD Million)
  • TABLE Latin America Liver Cancer Diagnostic market, by End User, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Liver Cancer Diagnostic market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Liver Cancer Diagnostic market, by Screening Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Liver Cancer Diagnostic market, by End User, 2015-2026 (USD Million)

List of Figures

  • FIGURE Liver Cancer Diagnostic market segmentation
  • FIGURE Market research Screening Typeology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Screening Type segment market share analysis, 2019 & 2026
  • FIGURE Screening Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE End User segment market share analysis, 2019 & 2026
  • FIGURE End User segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Liver Cancer Diagnostic market share and leading players, 2018
  • FIGURE Europe Liver Cancer Diagnostic market share and leading players, 2018
  • FIGURE Asia Pacific Liver Cancer Diagnostic market share and leading players, 2018
  • FIGURE Latin America Liver Cancer Diagnostic market share and leading players, 2018
  • FIGURE Middle East and Africa Liver Cancer Diagnostic market share and leading players, 2018
  • FIGURE North America Liver Cancer Diagnostic market share analysis by country, 2018
  • FIGURE U.S. Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Liver Cancer Diagnostic market share analysis by country, 2018
  • FIGURE Germany Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Liver Cancer Diagnostic market share analysis by country, 2018
  • FIGURE India Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Liver Cancer Diagnostic market share analysis by country, 2018
  • FIGURE Brazil Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Liver Cancer Diagnostic market share analysis by country, 2018
  • FIGURE Saudi Arabia Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Liver Cancer Diagnostic market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

Liver cancer diagnostic market was valued at USD 9.35 billion by 2019, growing with 8% CAGR during the forecast period, 2020-2026

Market Dynamics

The rising incidence of liver cancer owing to heavy consumption of alcohol and unhealthy eating habits is a major factor driving the growth of the global liver cancer diagnostic market. Regular consumption of alcohol, unhygienic or spicy food can damage the liver. According to the Centers for Disease Control and Prevention (CDC), around 33,000 people are diagnosed with liver cancer every year in the U.S., of which approximately 27,000 die from the disease. Thus, the awareness regarding the early diagnosis of liver cancer is growing amongst people, which is expected to impel the market growth during the forecast period.

Moreover, healthcare professionals are getting help by the advent of multiple procedures of screening to detect the problem at an early stage. However, the dearth of skilled healthcare professionals and lack of awareness regarding technological advancements are expected to restrict market growth in the coming future.

Screening Type Takeaway

Laboratory tests segment is expected to hold the majority of share in the market during the period of forecast. These tests are further categorized into blood tests and biomarkers. Such diagnostic techniques enable healthcare professionals to ensure the presence of cancerous cells in the body. On the other hand, imaging tests allow doctors to take clear images of internal organs. This ensures the presence of tumor in the human body. Such tests include x-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and other radiographic tests. Thus, the imaging segment is anticipated to grow at a significant rate during the forecast period.

End User Takeaway

Hospital associated labs end-user segment is anticipated to subjugate the global liver cancer diagnostic industry throughout the forecast. This dominance is attributed to the rising number of hospital visits by people for conducting tests. Along with hospital-associated labs, cancer research institutes are projected to gain traction among patients and healthcare facilities. This is mainly because of continuous research carried out on the development of effective therapeutic methods. The aim of this research is to reduce the worldwide mortality rate.

REGIONAL TAKEAWAY

Presently, the North America region holds the majority of market share and is expected to maintain its lead throughout the forecast. This is majorly owing to well-established healthcare infrastructure and early adoption of new diagnostic approaches among medical facilities in this region. Moreover, constant R&D activities carried out by professionals to introduce effective therapeutic methods and rising base of the target population are some of the factors predicted to boost the regional market growth.

The Asia Pacific, on the other hand, is also estimated to exhibit substantial CAGR owing to a rise in the number of patients suffering from several liver problems. The healthcare infrastructure is improving in the emerging economies of China and India. Also, the treatment costs are reducing in this region, which will impel the regional market during the forecast period. In addition, the governments of the Asia Pacific countries are taking initiatives to support manufacturers of medical devices, which will likely create lucrative opportunities in the market.

Key vendors of the market include:

  • Thermo Fisher Scientific.
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen
  • Danaher Corporation

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2015 to 2018
  • Base Year - 2019
  • Estimated Year - 2020
  • Projected Year - 2026

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVER CANCER DIAGNOSTIC MARKET, BY SCREENING TYPE

  • Biopsy
  • Endoscopy
  • Imaging
  • Laboratory Tests
  • Blood Tests
  • Biomarkers
  • Enzymes and Isoenzymes
  • Pathological Biomarkers
  • Oncofetal and Glycoprotein Antigens
  • Growth Factors and Receptors
  • Molecular Markers

GLOBAL LIVER CANCER DIAGNOSTIC MARKET, BY END USER

  • Independent Laboratories
  • Hospital Associated Labs
  • Cancer Research Institutes
  • Others

GLOBAL LIVER CANCER DIAGNOSTIC MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

TABLE OF CONTENT

1. LIVER CANCER DIAGNOSTIC MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Screening Type
    • 2.1.2. Market Snippet by End User
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. LIVER CANCER DIAGNOSTIC KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. LIVER CANCER DIAGNOSTIC INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. LIVER CANCER DIAGNOSTIC MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. LIVER CANCER DIAGNOSTIC MARKET - BY SCREENING TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Screening Type, 2019 & 2026 (%)
  • 6.2. Biopsy
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Endoscopy
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Imaging
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.5. Laboratory Tests
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.5.3. Blood Tests
      • 6.5.3.1. Overview
      • 6.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.5.4. Biomarkers
      • 6.5.4.1. Overview
      • 6.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.5.4.3. Enzymes and Isoenzymes
      • 6.5.4.3.1. Overview
      • 6.5.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.5.4.4. Pathological Biomarkers
      • 6.5.4.4.1. Overview
      • 6.5.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.5.4.5. Oncofetal and Glycoprotein Antigens
      • 6.5.4.5.1. Overview
      • 6.5.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.5.4.6. Growth Factors and Receptors
      • 6.5.4.6.1. Overview
      • 6.5.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.5.4.7. Molecular Markers
      • 6.5.4.7.1. Overview
      • 6.5.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. LIVER CANCER DIAGNOSTIC MARKET - BY END USE

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
  • 7.2. Independent Laboratories
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Hospital Associated Labs
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Cancer Research Institutes
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Others
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. LIVER CANCER DIAGNOSTIC MARKET- BY GEOGRAPHY

  • 8.1. Introduction
    • 8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Key Manufacturers in North America
    • 8.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.2.4. North America Market Size and Forecast, By Screening Type, 2015 - 2026 (US$ Million)
    • 8.2.5. North America Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 8.2.6. U.S.
      • 8.2.6.1. Overview
      • 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.2.7. Canada
      • 8.2.7.1. Overview
      • 8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Key Manufacturers in Europe
    • 8.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.3.4. Europe Market Size and Forecast, By Screening Type, 2015 - 2026 (US$ Million)
    • 8.3.5. Europe Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 8.3.6. Germany
      • 8.3.6.1. Overview
      • 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.7. Italy
      • 8.3.7.1. Overview
      • 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.8. United Kingdom
      • 8.3.8.1. Overview
      • 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.9. France
      • 8.3.9.1. Overview
      • 8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.10. Rest of Europe
      • 8.3.10.1. Overview
      • 8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Key Manufacturers in Asia Pacific
    • 8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.4.4. Asia Pacific Market Size and Forecast, By Screening Type, 2015 - 2026 (US$ Million)
    • 8.4.5. Asia Pacific Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 8.4.6. India
      • 8.4.6.1. Overview
      • 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.7. China
      • 8.4.7.1. Overview
      • 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.8. Japan
      • 8.4.8.1. Overview
      • 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.9. South Korea
      • 8.4.9.1. Overview
      • 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.10. Rest of APAC
      • 8.4.10.1. Overview
      • 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. Latin America
    • 8.5.1. Overview
    • 8.5.2. Key Manufacturers in Latin America
    • 8.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.5.4. Latin America Market Size and Forecast, By Screening Type, 2015 - 2026 (US$ Million)
    • 8.5.5. Latin America Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 8.5.6. Brazil
      • 8.5.6.1. Overview
      • 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.5.7. Mexico
      • 8.5.7.1. Overview
      • 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.5.8. Argentina
      • 8.5.8.1. Overview
      • 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.5.9. Rest of LATAM
      • 8.5.9.1. Overview
      • 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Overview
    • 8.6.2. Key Manufacturers in Middle East and Africa
    • 8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.6.4. Middle East and Africa Market Size and Forecast, By Screening Type, 2015 - 2026 (US$ Million)
    • 8.6.5. Middle East and Africa Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 8.6.6. Saudi Arabia
      • 8.6.6.1. Overview
      • 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.6.7. United Arab Emirates
      • 8.6.7.1. Overview
      • 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. KEY VENDOR ANALYSIS

  • 9.1. Thermo Fisher Scientific.
    • 9.1.1. Company Snapshot
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Strategic Initiatives
  • 9.2. Siemens Healthcare GmbH
  • 9.3. Sysmex Corporation
  • 9.4. Illumina, Inc.
  • 9.5. F. Hoffmann-La Roche Ltd.
  • 9.6. Qiagen
  • 9.7. Danaher Corporation

10. 360 DEGREE ANALYSTVIEW

11. APPENDIX

  • 11.1. Research Methodology
  • 11.2. References
  • 11.3. Abbreviations
  • 11.4. Disclaimer
  • 11.5. Contact Us